ATE469615T1 - Künstliches, vaskuläres transplantat sowie verfahren zu seiner herstellung und seinem gebrauch - Google Patents

Künstliches, vaskuläres transplantat sowie verfahren zu seiner herstellung und seinem gebrauch

Info

Publication number
ATE469615T1
ATE469615T1 AT01956749T AT01956749T ATE469615T1 AT E469615 T1 ATE469615 T1 AT E469615T1 AT 01956749 T AT01956749 T AT 01956749T AT 01956749 T AT01956749 T AT 01956749T AT E469615 T1 ATE469615 T1 AT E469615T1
Authority
AT
Austria
Prior art keywords
production
intravascular
inhibitor
treating
growth factor
Prior art date
Application number
AT01956749T
Other languages
English (en)
Inventor
Moshe Flugelman
Meir Preis
Zoya Gluzman
Belly Koren
Anat Weisz
Tzafra Cohen
Original Assignee
Mgvs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mgvs Ltd filed Critical Mgvs Ltd
Application granted granted Critical
Publication of ATE469615T1 publication Critical patent/ATE469615T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/383—Nerve cells, e.g. dendritic cells, Schwann cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3826—Muscle cells, e.g. smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
AT01956749T 2000-07-20 2001-07-20 Künstliches, vaskuläres transplantat sowie verfahren zu seiner herstellung und seinem gebrauch ATE469615T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62022700A 2000-07-20 2000-07-20
PCT/IL2001/000670 WO2002007646A2 (en) 2000-07-20 2001-07-20 Artificial vascular grafts, and methods of producing and using same

Publications (1)

Publication Number Publication Date
ATE469615T1 true ATE469615T1 (de) 2010-06-15

Family

ID=24485086

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01956749T ATE469615T1 (de) 2000-07-20 2001-07-20 Künstliches, vaskuläres transplantat sowie verfahren zu seiner herstellung und seinem gebrauch

Country Status (13)

Country Link
US (4) US7364725B1 (de)
EP (1) EP1301146B1 (de)
JP (1) JP5067822B2 (de)
AT (1) ATE469615T1 (de)
AU (1) AU2001278664A1 (de)
CA (1) CA2416548A1 (de)
CZ (1) CZ2003253A3 (de)
DE (1) DE60142290D1 (de)
HU (1) HUP0300810A2 (de)
IL (1) IL153946A0 (de)
PL (1) PL362561A1 (de)
WO (1) WO2002007646A2 (de)
ZA (1) ZA200300635B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485723B1 (en) 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
JP5859179B2 (ja) * 2000-03-15 2016-02-10 オーバスネイチ メディカル、インコーポレイテッド 内皮細胞接着を促進するコーティング
US7175658B1 (en) 2000-07-20 2007-02-13 Multi-Gene Vascular Systems Ltd. Artificial vascular grafts, their construction and use
HUP0300810A2 (hu) 2000-07-20 2003-08-28 M.G.V.S. Ltd. Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
EP1482871A4 (de) * 2002-02-19 2006-09-13 Bioarttis Inc Künstliches gefässgerüst und künstliche organe daraus
EP2103684A1 (de) 2002-05-02 2009-09-23 Purdue Research Foundation Gefäßneubildungserweiterte Transplantationskonstrukte
JP2005533535A (ja) * 2002-05-02 2005-11-10 パーデュー・リサーチ・ファウンデーション 血管新生が促進された移植片構成物
US20050202058A1 (en) * 2002-05-02 2005-09-15 Hiles Michael C. Cell-seeded extracellular matrix grafts
CN1684589A (zh) 2002-05-02 2005-10-19 普渡研究基金会 血管化增强的移植构造物
CA2563329C (en) 2004-04-30 2016-01-26 Orbus Medical Technologies, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
WO2006017275A1 (en) 2004-07-13 2006-02-16 The University Of Tennessee Research Foundation Adhesive composition for carrying therapeutic agents as delivery vehicle on coatings applied to vascular grafts
EP1984040A1 (de) * 2006-01-31 2008-10-29 Multi Gene Vascular Systems, Inc. Arznei-eluierende intravaskuläre prothesen und verwendungsverfahren
JP5839814B2 (ja) * 2010-03-17 2016-01-06 グンゼ株式会社 Ｄａｎｃｅタンパク質含有徐放基材及び該徐放基材の製造方法
EP3443991A1 (de) 2010-05-25 2019-02-20 Cook Biotech Incorporated Verfahren, substrate und systeme zur zellenaussetzung von medizinischen transplantaten
US20140065110A1 (en) * 2012-08-31 2014-03-06 The Regents Of The University Of California Genetically modified msc and therapeutic methods
US9663564B2 (en) 2013-03-15 2017-05-30 The Regents Of The University Of California Vectors and methods to treat ischemia
WO2014070792A1 (en) 2012-10-29 2014-05-08 Ariste Medical, Inc. Polymer coating compositions and coated products
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
GB2537770B (en) 2014-04-22 2017-09-13 Ariste Medical Llc Methods and processes for application of drug delivery polymeric coatings
EP4548939A3 (de) 2014-08-27 2025-08-06 Purdue Research Foundation Abgabesysteme für therapeutikum auf kollagenbasis
US20190030125A1 (en) * 2014-12-07 2019-01-31 Vessl Therapeutics Ltd Use of fibulin-5 for the treatment of keloid scars
WO2016140716A1 (en) 2015-03-02 2016-09-09 The Trustees Of Columbia University In The City Of New York Injectable microtissue systems, devices, and methods
US11919941B2 (en) 2015-04-21 2024-03-05 Purdue Research Foundation Cell-collagen-silica composites and methods of making and using the same
EP3325444B1 (de) 2015-07-20 2021-07-07 Acadia Pharmaceuticals Inc. Verfahren zur herstellung von n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy) phenylmethyl)carbamide und seinem tartrat-salt und seiner polymorphen form c
CN106075585B (zh) * 2016-07-08 2019-06-21 福建师范大学 一种基于人工肌腱支架材料的组织工程化人工肌腱移植物的制备方法
CN110129253A (zh) * 2016-09-14 2019-08-16 四川蓝光英诺生物科技股份有限公司 人工组织前体及制备其的方法
US11439731B2 (en) 2016-09-14 2022-09-13 Revotek Co., Ltd. Artificial tissue progenitor and method for preparing the same
ES3040675T3 (en) 2017-01-31 2025-11-04 Geniphys Inc Methods and compositions for matrix preparation
US11739291B2 (en) 2017-04-25 2023-08-29 Purdue Research Foundation 3-dimensional (3D) tissue-engineered muscle for tissue restoration
WO2020023957A1 (en) * 2018-07-27 2020-01-30 Washington University Cell-embedded vascular graft for transplantation
CA3168904A1 (en) 2020-01-27 2021-08-05 Geniphys, Inc. Biologic filler for restoring and regenerating tissue
US20220145258A1 (en) * 2020-11-10 2022-05-12 Vessl Therapeutics Ltd Methods of preconditioning vascular cells for transduction, methods of transduction and methods of preserving transduced cells

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
ES2004281A6 (es) 1986-04-04 1988-12-16 Univ Jefferson Una superficie protesica implantable para implantacion en un paciente humano
DE3854823T2 (de) 1987-05-01 1996-05-23 Stratagene Inc Mutagenesetest durch Verwendung von nicht menschlichen Lebewesen, die Test-DNS-Sequenzen enthalten
US5175385A (en) 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
US5674722A (en) * 1987-12-11 1997-10-07 Somatix Therapy Corporation Genetic modification of endothelial cells
US6001350A (en) 1987-12-11 1999-12-14 Somatix Therapy Corp Genetic modification of endothelial cells
US5221778A (en) 1988-08-24 1993-06-22 Yale University Multiplex gene regulation
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5175383A (en) 1989-02-17 1992-12-29 President And Fellows Of Harvard College Animal model for benign prostatic disease
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5498238A (en) 1990-06-15 1996-03-12 Cortrak Medical, Inc. Simultaneous angioplasty and phoretic drug delivery
WO1991019810A1 (en) 1990-06-15 1991-12-26 California Biotechnology Inc. Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
US5288846A (en) 1990-10-19 1994-02-22 The General Hospital Corporation Cell specific gene regulators
WO1992011895A1 (en) 1990-12-28 1992-07-23 Boston Scientific Corporation Balloon drug delivery system
US5925564A (en) 1991-11-06 1999-07-20 Baylor College Of Medicine Expression vector systems and method of use
US5298422A (en) 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
JPH07506720A (ja) 1992-01-07 1995-07-27 アテナ　ニューロサイエンシーズ，　インコーポレイテッド アルツハイマー病のトランスジェニック動物モデル
US5360735A (en) 1992-01-08 1994-11-01 Synaptic Pharmaceutical Corporation DNA encoding a human 5-HT1F receptor, vectors, and host cells
US5599352A (en) 1992-03-19 1997-02-04 Medtronic, Inc. Method of making a drug eluting stent
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
WO1994006908A1 (en) 1992-09-11 1994-03-31 The Regents Of The University Of California Transgenic non-human animals having targeted lymphocyte transduction genes
US5634901A (en) 1992-11-02 1997-06-03 Localmed, Inc. Method of using a catheter sleeve
WO1994023049A2 (en) 1993-04-02 1994-10-13 The Johns Hopkins University The introduction and expression of large genomic sequences in transgenic animals
US6664107B1 (en) 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
ES2255477T5 (es) 1993-07-29 2010-04-08 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Uso de paclitaxel y sus derivados en la fabricacion de un medicamento para el tratamiento de reestenosis.
US5736360A (en) * 1993-09-10 1998-04-07 The Trustees Of The University Of Pennsylvania Endothelial cell tropic compositions and methods of making and using the same
WO1995025547A1 (en) * 1994-03-24 1995-09-28 University Of Washington Devices and methods for implanting transduced cells
US5700346A (en) * 1994-07-19 1997-12-23 Edwards; Peter S. Automated slide staining system
US6425881B1 (en) 1994-10-05 2002-07-30 Nitrosystems, Inc. Therapeutic mixture useful in inhibiting lesion formation after vascular injury
ATE434423T1 (de) 1994-10-17 2009-07-15 Igaki Iryo Sekkei Kk Medikamentenfreisetzender stent
US20020026037A1 (en) * 1995-06-06 2002-02-28 Jing-Shan Hu Vascular endothelial growth factor 3 antibodies
WO1997023256A1 (en) 1995-12-22 1997-07-03 Localmed, Inc. Localized intravascular delivery of growth factors for promotion of angiogenesis
US5785965A (en) * 1996-05-15 1998-07-28 The Board Of Trustees Of The Leland Stanford Junior Univ. VEGF gene transfer into endothelial cells for vascular prosthesis
ATE343400T1 (de) * 1996-09-24 2006-11-15 Merck & Co Inc Verbindungen zur hemmung der angiogenese durch gentherapie
EP2008664B1 (de) * 1997-04-10 2012-08-29 University Of Southern California Modifizierte Proteine zur Bindung extrazellulärer Matrixkomponenten
WO1998056312A1 (en) 1997-06-13 1998-12-17 Scimed Life Systems, Inc. Stents having multiple layers of biodegradable polymeric composition
US5872234A (en) 1997-06-27 1999-02-16 Incyte Pharmaceuticals, Inc. Human extracellular matrix proteins
US5899935A (en) 1997-08-04 1999-05-04 Schneider (Usa) Inc. Balloon expandable braided stent with restraint
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
EP1053326A2 (de) * 1998-02-06 2000-11-22 Collateral Therapeutics Varianten des angiogenen faktors vaskularer endothelialzell-wachstumsfaktor: vegf
US6364856B1 (en) 1998-04-14 2002-04-02 Boston Scientific Corporation Medical device with sponge coating for controlled drug release
KR20010043088A (ko) 1998-04-28 2001-05-25 우에노 도시오 신규인 폴리펩티드, 그 폴리펩티드를 코드화하는 ｃＤＮＡ및 그 용도
US6010573A (en) * 1998-07-01 2000-01-04 Virginia Commonwealth University Apparatus and method for endothelial cell seeding/transfection of intravascular stents
EP1568375A1 (de) 1998-10-26 2005-08-31 Ludwig Institute For Cancer Research Verwendung von VEGF-C oder VEGF-D Genen oder Proteinen zur Vorbeugung der Restenose
US6328762B1 (en) * 1999-04-27 2001-12-11 Sulzer Biologics, Inc. Prosthetic grafts
US6554857B1 (en) 1999-07-20 2003-04-29 Medtronic, Inc Transmural concentric multilayer ingrowth matrix within well-defined porosity
US6589534B1 (en) * 1999-09-30 2003-07-08 Yeda Research And Development Co., Ltd. Hepatitis B virus binding proteins and uses thereof
US6716242B1 (en) 1999-10-13 2004-04-06 Peter A. Altman Pulmonary vein stent and method for use
US20030229393A1 (en) 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
HUP0300810A2 (hu) * 2000-07-20 2003-08-28 M.G.V.S. Ltd. Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
US7175658B1 (en) * 2000-07-20 2007-02-13 Multi-Gene Vascular Systems Ltd. Artificial vascular grafts, their construction and use
US6939376B2 (en) 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
AU2003228382A1 (en) 2002-03-27 2003-10-13 University Of Utah Research Foundation Elastin prevents occlusion of body vessels by vascular smooth muscle cells
US20040126788A1 (en) 2002-08-13 2004-07-01 Schiemann William P. Fibulin-5 and uses thereof
US6918929B2 (en) 2003-01-24 2005-07-19 Medtronic Vascular, Inc. Drug-polymer coated stent with pegylated styrenic block copolymers
KR100856360B1 (ko) 2004-03-29 2008-09-04 고쿠리츠 다이가쿠 호진 교토 다이가쿠 절단형 ｄａｎｃｅ, ｄａｎｃｅ 복합체, 및 이들을사용하는 방법
WO2005099695A1 (en) 2004-04-19 2005-10-27 Novartis Ag Drug delivery systems for the prevention and treatment of vascular diseases
JP5032973B2 (ja) 2005-02-07 2012-09-26 学校法人関西医科大学 Ｄａｎｃｅまたはその発現を増強する因子による弾性線維再生の方法
EP1984040A1 (de) 2006-01-31 2008-10-29 Multi Gene Vascular Systems, Inc. Arznei-eluierende intravaskuläre prothesen und verwendungsverfahren

Also Published As

Publication number Publication date
PL362561A1 (en) 2004-11-02
US8022195B2 (en) 2011-09-20
JP2004506418A (ja) 2004-03-04
HUP0300810A2 (hu) 2003-08-28
US8088160B2 (en) 2012-01-03
WO2002007646A2 (en) 2002-01-31
AU2001278664A1 (en) 2002-02-05
CA2416548A1 (en) 2002-01-31
EP1301146B1 (de) 2010-06-02
EP1301146A2 (de) 2003-04-16
CZ2003253A3 (cs) 2003-05-14
ZA200300635B (en) 2004-04-22
DE60142290D1 (de) 2010-07-15
WO2002007646A3 (en) 2002-06-13
US20090263452A1 (en) 2009-10-22
US20060275338A1 (en) 2006-12-07
IL153946A0 (en) 2003-07-31
US7563278B2 (en) 2009-07-21
US7364725B1 (en) 2008-04-29
EP1301146A4 (de) 2008-11-19
JP5067822B2 (ja) 2012-11-07
US20080269472A1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
DE60142290D1 (de) Künstliches, vaskuläres transplantat sowie verfahren zu seiner herstellung und seinem gebrauch
ATE446777T1 (de) Arzneimittel abgebender endovaskulärer stent und vrefahren zur behandlung von restenose
ATE205776T1 (de) Verfahren zur herstellung von radial expandierbaren, bandverstärkten polytetrafluoräthylengefässtransplantaten
Nakayama et al. In vivo tissue-engineered small-caliber arterial graft prosthesis consisting of autologous tissue (biotube)
WO2004075781A3 (en) Bioactive stents and methods for use thereof
ATE509641T1 (de) Beschichtung für implantierbare vorrichtungen und verfahren zu ihrer herstellung
WO2004060318A3 (en) Drug-coated stents and methods of use therefor
DE60130032D1 (de) Vorrichtung zur Abgabe von therapeutischen Wirkstoffen
ATE382310T1 (de) Verfahren zum zusammendrücken einer endoprothese
WO2004030678A8 (en) Polymer compositions containing bioactive agents and methods for their use
DE602004024053D1 (de) Metallische implantierbare prothesen und herstellungsverfahren dafür
WO2002074194A3 (en) Stent with medicated multi-layer hydrid polymer coating
ATE339975T1 (de) Anti-angiogener stent und verfahren zu dessen herstellung
ATE406909T1 (de) Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
EP1308180A4 (de) Stent fur ein blutgefass und material fur eine vaskulare endoprothese
DE602007013004D1 (de) Beschichtete medizinische vorrichtungen und verfahren zu ihrer herstellung
DE69831608D1 (de) Prothese im inneren eines gefässes
MXPA05011620A (es) Dispositivos medicos y metodos para inhibir la proliferacion de celulas de musculo liso.
CN101820932A (zh) 释放铁离子的内置假体
WO2000033770A3 (en) Multi-stage expandable stent-graft
WO2003090818A3 (en) Drug-delivery endovascular stent and method for treating restenosis
WO2004000379A8 (en) Stent coatings with sustained drug release rate
WO2003013337A3 (en) Medical grafts having plurality of microperforations
WO2005007019A3 (en) Implantable surgical mesh having a lubricious coating
MX2009012766A (es) Stent absorbible con un recubrimiento para controlar la degradacion del stent y mantener la neutralidad del ph.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties